← Open Payments lookup

VALERIA BERMUDEZ: Open Payments

NPI 1992158257 · BROWNSVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$885 in 47 payments from 14 companies in 2025. Trend: 2023 $1,548 · 2024 $996 · 2025 $885

Food & beverage: $885
CompanyPaymentsAmount
Lilly USA, LLC15$308
Novo Nordisk Inc14$164
Mayne Pharma Commercial LLC1$125
AstraZeneca Pharmaceuticals LP4$62
Sumitomo Pharma America, Inc.2$37
GlaxoSmithKline, LLC.2$30
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$29
Insulet Corporation1$22
Novartis Pharmaceuticals Corporation1$21
Bayer Healthcare Pharmaceuticals Inc.1$20

Products named: ZEPBOUND, MOUNJARO, ANNOVERA, Ozempic, AIRSUPRA, Wegovy, GEMTESA, SHINGRIX.

Industry payments across TX — which companies pay providers there.